Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. - Wikidata - wikimedia - TriplyDB

Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.

Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.

http://www.wikidata.org/entity/Q37241865

about

Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review Local ablation for hepatocellular carcinoma in taiwan Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation Radioembolization of hepatic tumors Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.An evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithm Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.Minimally invasive local therapies for liver cancer Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times.Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.Locally ablative therapies for primary and metastatic liver cancer.Presentation and outcomes of hepatocellular carcinoma patients at a western centre.Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives.Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma.Determinants and outcomes of adherence to recommendations from a multidisciplinary tumour conference for hepatocellular carcinoma Current status of multimodal & combination therapy for hepatocellular carcinoma.Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.Recurrence after microwave ablation of liver malignancies: a single institution experience.Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics Nonsurgical treatment for localized hepatocellular carcinoma.Independent prognostic factors for posttransplant survival in hepatocellular carcinoma patients undergoing liver transplantation.Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis.Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database.Surgical treatment of hepatocellular carcinoma: expert consensus statement.Surgical treatment for large hepatocellular carcinoma: does size matter?Patient selection for liver transplantation.Treatment of hepatocellular carcinoma: a systematic review.Hepatic radioembolization as a bridge to liver surgery.Ablation for hepatocellular carcinoma: validating the 3-cm breakpoint.Radiofrequency ablation of liver tumors: Actual limitations and potential solutions in the future.Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.Impact of preoperative locoregional therapy on recurrence and patient survival following liver transplantation for hepatocellular carcinoma: a meta-analysis.Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.CT-guided Interstitial Brachytherapy of Hepatocellular Carcinoma before Liver Transplantation: an Equivalent Alternative to Transarterial Chemoembolization?Multimodality locoregional treatment strategies for bridging HCC patients before liver transplantation.Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: a meta-analysis.Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.AASLD guidelines for the treatment of hepatocellular carcinoma

P2860

Q24635267-8AF7A116-9856-4C13-948C-0AD2563602BA Q26741882-57426D75-5819-47B2-8DD8-1564E2085592 Q26829892-58663851-38F1-440E-82F2-BB45A2C02BA6 Q26852105-50A3B6EE-8B47-4C92-9D75-599FF1114391 Q33820777-F07681E0-7712-43FF-A585-18D0DD90B637 Q34131801-87290F4A-09B9-4512-9406-80B4DC13F6A5 Q34417009-BFD662E4-D1D6-496E-9A3D-7EE7257F30F7 Q34483032-90A0D1A9-3C46-4D8C-8E7D-FB155C1F812A Q34974386-3989D315-CF2A-453C-B78E-90148AE7BC37 Q35064605-57910EF5-1072-439E-9E26-39B68E20D4FE Q35081063-F3510932-A38D-4E38-8140-C94C3C495DB9 Q35152457-7B7A7C30-02DF-46F9-A9B6-4FDA81076C0B Q35535968-98543F4E-C330-485A-8AB0-BE5AA3892E31 Q35626761-F80CE557-145B-4EC3-B3B0-8AB27F57BB70 Q35668720-833A612D-085F-4D84-A19B-366A4F9490F7 Q35805862-6678913F-0409-4DE2-80CB-0C9CE556EAC6 Q36436294-F04052FE-2FF5-4118-8512-DC5FFA123918 Q36720150-51BF8CBE-664F-411D-B21F-97BA762417CA Q36786156-967D8F1C-31C1-49BD-B6D5-ABFFE543DD61 Q36962089-1F8C392D-312F-4C4D-AD80-19381DAD9EDC Q37355835-D5394663-8E06-4308-9E82-3231E43E5B54 Q37578521-067BB32A-4EFD-4B99-ABA6-288A069CF408 Q37609440-2C168EB3-773F-4FC3-B575-05A4DEEC9CF3 Q37636484-727C7105-C2BB-4EDC-8903-D99B59E6D8C8 Q37697170-2E3A6AB8-6EB9-4887-B25D-2704F0C7C1DD Q37768894-373C73B8-90C9-41CC-AFF7-2877BA8BF099 Q38006772-5A554A06-9174-451C-B936-95360933FF04 Q38132281-462CE2B9-09BB-48AF-9F7E-4D6BD60DB7D0 Q38155508-8F9066F2-89E9-41E2-B4F4-84FC912925C2 Q38240151-49AEBD2A-BC95-4EA7-849F-B91E3D5F4F8E Q39410834-4223D4C6-B4C5-4947-B1D4-6EBF1BF98CED Q39784584-32519FC6-DB1C-4B64-BCB1-AD8187EAA424 Q40450035-4D9AAFA6-6B12-44A3-9450-9793FA55292B Q40583626-CC2520E9-BBCB-466C-A0CC-792DFC0BDBBF Q40586816-7E3A1E7E-7F00-4D48-A91F-A3056AA8C700 Q41308909-756010DF-D4BF-4AAC-B4BE-F79FA3AD4DC0 Q47100371-CAB19FA3-B092-4204-AD8A-224F27BE8CF2 Q47573274-FA4C69C4-B466-4DC7-86A4-D65F98398A97 Q50244078-31AD458A-EABF-42CD-8103-84571FF74163 Q56172239-C5644DEB-9042-48B7-B625-C8633C3C2874

P2860

Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.

http://www.wikidata.org/entity/Q37241865

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bridging locoregional therapy ...... rior to liver transplantation.

@en

Bridging locoregional therapy ...... rior to liver transplantation.

@nl

type

label

Bridging locoregional therapy ...... rior to liver transplantation.

@en

Bridging locoregional therapy ...... rior to liver transplantation.

@nl

prefLabel

Bridging locoregional therapy ...... rior to liver transplantation.

@en

Bridging locoregional therapy ...... rior to liver transplantation.

@nl

P1433

Q37241865-B5B1E1D4-E126-482C-838F-B6A12660CF91

P1476

Q37241865-DE02CA33-C98C-4A3B-8091-F2B4B0EC180E

P2093

Q37241865-06E72B15-5774-4C6B-BB1A-323A52354BA5

Q37241865-3CDFDEA2-69CA-411F-B830-1E72E3161D52

Q37241865-4BDE1687-BE50-400A-ABD9-D35CAFDC4362

Q37241865-6760FC94-B5A8-48B5-BB31-3902093B3BEB

Q37241865-8A1D7D44-89C5-4089-A138-C07F8841B330

Q37241865-8D881E29-CA8D-4F2D-AF9A-B1B215D64A74

Q37241865-9DEA548D-E670-4FF8-9925-16EAFB861B21

Q37241865-EE7E5618-BB83-40E4-899B-8300FF74F0DD

Q37241865-F942DF1B-BE99-42CD-8010-4D9ADD12BFC5

Q37241865-F9C39C99-C683-479A-8BE5-366A086555CD

P2860

Q37241865-7AB74E92-B2D6-4EBA-A00A-24FE7A9D554F

Q37241865-EEFB0F2A-E3D0-473F-92D1-668D31F95E0B

P2888

Q37241865-5CC2038D-7526-41CD-A901-BA5E5E20EB09

P304

Q37241865-3A7C2812-002E-4CB4-AD2F-7BFBBCA8171C

P31

Q37241865-54943AAF-5A5B-4B9D-8049-9D0BF8A189BB

P356

Q37241865-408FD0C9-5969-48DD-8DC3-BDD66941ED5B

P433

Q37241865-F82747FC-FFE0-4276-BCE8-A3760C71DC97

P478

Q37241865-795347F6-D5FE-47FA-AB11-E3A3ED0D4799

P577

Q37241865-665CB426-525A-404B-B3DA-E8F8EE5103FD

P6179

Q37241865-8E871625-90AB-463C-9715-ED22E91EEDCD

P698

Q37241865-AAEE14F2-4AC4-4426-B410-2EE79508E101

P921

Q37241865-6F3CF6C3-B49C-425C-A983-0C75A1A461D7

P356

S10434-008-0071-3

P1433

Annals of Surgical Oncology

P1476

Bridging locoregional therapy ...... rior to liver transplantation.

@en

P2093

David A Geller

http://www.w3.org/2001/XMLSchema#string

J Wallis Marsh

http://www.w3.org/2001/XMLSchema#string

Jason T Heckman

http://www.w3.org/2001/XMLSchema#string

Jennifer L Steel

http://www.w3.org/2001/XMLSchema#string

Michael B Devera

http://www.w3.org/2001/XMLSchema#string

Michael Nalesnik

http://www.w3.org/2001/XMLSchema#string

Nikhil B Amesur

http://www.w3.org/2001/XMLSchema#string

Paulo Fontes

http://www.w3.org/2001/XMLSchema#string

Shane E Holloway

http://www.w3.org/2001/XMLSchema#string

T Clark Gamblin

http://www.w3.org/2001/XMLSchema#string

P2860

Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation.

Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.

P2888

s10434-008-0071-3

P304

3169-3177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-008-0071-3

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1018813881

http://www.w3.org/2001/XMLSchema#string

P698

18696158

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation